LGR5 and breast carcinoma: Moreover, the CSC-associated marker leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) has been previously shown to promote breast cancer progression and CSC maintenance, in part through activation of Wnt/β-catenin signaling [5].